InVivoMAb anti-mouse LFA-1alpha (CD11a)
BE0005-1
ApplicationsNeutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
 - Product NameInVivoMAb anti-mouse LFA-1alpha (CD11a)
 - Delivery Days Customer7
 - ApplicationsNeutralisation/Blocking
 - CertificationResearch Use Only
 - ClonalityMonoclonal
 - Clone IDFD441.8
 - Concentration4-11 mg/ml
 - Estimated Purity>95%
 - HostRat
 - IsotypeIgG2b
 - Storage Instruction2°C to 8°C
 - UNSPSC12352203
 
References
- Endogenous memory CD8 T cells directly mediate cardiac allograft rejection. Su CA et al., 2014 Mar, Am J TransplantRead more
 - Endogenous memory CD8 T cells are activated within cardiac allografts without mediating rejection. Setoguchi K et al., 2013 Sep, Am J TransplantRead more
 - Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy. Ashkenazi E et al., 2013, PLoS OneRead more
 - LFA-1 antagonism inhibits early infiltration of endogenous memory CD8 T cells into cardiac allografts and donor-reactive T cell priming. Setoguchi K et al., 2011 May, Am J TransplantRead more
 - Hapten application to the skin induces an inflammatory program directing hapten-primed effector CD8 T cell interaction with hapten-presenting endothelial cells. Kish DD et al., 2011 Feb 15, J ImmunolRead more
 - Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice. James SE et al., 2009 Dec 24, BloodRead more